Mary J. Bartholomew - Concepedia

Author

Mary J. Bartholomew

Also Known As

Bartholomew, Mary J., M Bartholomew, M J Bartholomew, M. BARTHOLOMEW, M. Bartholomew, M.J. Bartholomew, MARY BARTHOLOMEW, MARY J. BARTHOLOMEW, MARY Jo BARTHOLOMEW, Mary Bartholomew

Publications

2.7K

Citations

H-Index

138

Concepts

All Affiliations

Pennsylvania State University Penn State Milton S. Hershey Medical Center Center for Veterinary Medicine United States Food and Drug Administration University of Oklahoma Health Sciences Center

About

Mary J. Bartholomew is an author at Pennsylvania State University specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	33	2.1K
2	Health Sciences	9	9	912
3	Public Health	7	7	489
4	Nursing	4	4	203
5	Engineering	1	1	14

Mary J. Bartholomew

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Antimicrobial Drug Resistance in<i>Escherichia coli</i>from Humans and Food Animals, United States, 1950–2002 Daniel A. Tadesse, Shaohua Zhao, Emily T.Y. Tong, Emerging infectious diseases E. ColiAntibiotic ResistanceUnited StatesFood Animal SamplesDrug Resistance	2012	457
Clinical signs of androgen excess as risk factors for coronary artery disease Robert A. Wild, Blair P. Grubb, Arthur J. Hartz, Fertility and Sterility Vascular DiseaseCardiovascular DiseaseAtherosclerosisClinical SignsRisk Factors	1990	183
Aromatase activity in primary and metastatic human breast cancer Allan Lipton, Steven J. Santner, Richard J. Santen, Cancer Breast OncologyEndocrine-related CancerBiochemistryMedicineAromatase Activity	1987	134
Unmet needs of persons with cancer in pennsylvania during the period of terminal care Peter S. Houts, Harold A. Harvey, Arthur J. Hartz, Cancer Family MedicineFamily MembersCancer ManagementUnmet NeedsPrimary Care	1988	117
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome. Andrea Manni, Mary J. Bartholomew, Richard Caplan, Journal of Clinical Oncology Randomized Clinical TrialCancer ManagementPharmacotherapyMetronomic ChemotherapyOncology	1988	112
Aortic valve replacement and combined aortic valve replacement and coronary artery bypass grafting: Predicting high risk groups James A. Magovern, John L. Pennock, David B. Campbell, Journal of the American College of Cardiology Health PolicyCardiovascular DiseaseHigh Risk GroupsPatient SafetyAortic Valve Replacement	1987	105
The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome Robert A. Wild, Mary J. Bartholomew American Journal of Obstetrics and Gynecology ObesityMetabolic SyndromeLipid DisorderMetabolic DisorderGynecology	1988	94
Bladder and rectal complications following radiotherapy for cervix cancer John A. Stryker, Mary J. Bartholomew, Donald E. Velkley, Gynecologic Oncology Cervical CancerRadiation TherapyMedicineBrachytherapyCervix Cancer	1988	84
Transdermal Testosterone Therapy in the Treatment of Male Hypogonadism* S. Rafeeq Ahmed, Alice E. Boucher, Andrea Manni, The Journal of Clinical Endocrinology & Metabolism	1988	77
Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol Emmanuel C. Besa, Janet L. Abrahm, Mary J. Bartholomew, The American Journal of Medicine Hematological MalignancyOncologyMyelodysplastic SyndromeBone Marrow FailureMedicine	1990	76

Page 1